T1	Participants 401 456	patients treated in a referral cancer center in Brazil.
T2	Participants 465 596	Patients with stage I/II melanoma, consecutively submitted to a SLN procedure by the same surgeon from 2000 to 2006, were evaluated
T3	Participants 839 851	381 patients
